Laporan Laba Rugi (TTM)
Laporan Laba Rugi PD-Rx Pharmaceuticals, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2021 06-30 |
2022 06-30 |
2023 06-30 |
2024 06-30 |
|
|---|---|---|---|---|
| Revenue | 22 | 29 | 21 | 19 |
| Change (%) | 32.93 | -25.92 | -10.93 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 15 | 18 | 15 | 13 |
| Change (%) | 20.54 | -17.53 | -8.49 | |
| % of Revenue | 67.80 | 61.48 | 68.44 | 70.32 |
| Gross Operating Profit | 7 | 11 | 7 | 6 |
| Change (%) | 59.02 | -39.32 | -16.22 | |
| % of Revenue | 32.20 | 38.52 | 31.56 | 29.68 |
| SG&A | 6 | 7 | 7 | 7 |
| Change (%) | 16.08 | -2.19 | -4.74 | |
| % of Revenue | 28.15 | 24.58 | 32.45 | 34.71 |
| R&D | ||||
| Change (%) | ||||
| % of Revenue | ||||
| OpEx | 21 | 25 | 21 | 20 |
| Change (%) | 19.23 | -13.15 | -7.29 | |
| % of Revenue | 95.94 | 86.05 | 100.90 | 105.02 |
| Operating Income | 1 | 4 | -0 | -1 |
| Change (%) | 356.88 | -104.76 | 399.81 | |
| % of Revenue | 4.06 | 13.95 | -0.90 | -5.02 |
| Interest Expense | ||||
| Change (%) | ||||
| % of Revenue | ||||
| Net Income | 2 | 3 | -0 | -1 |
| Change (%) | 63.44 | -103.23 | 668.37 | |
| % of Revenue | 8.59 | 10.57 | -0.46 | -3.98 |
Source: Capital IQ
